(Reuters Health) - Testosterone treatment appears to improve the underlying problem in some men with type 2 diabetes, according to a study funded by UK drugmaker ProStrakan. The problem -- called “insulin resistance” -- is that the body doesn’t know how to use insulin to process sugar.